ScholarIQanswers from OpenAlex & ORCID
Ronald Ghossein
ResearcherPublications, citations & collaboration network
Ronald Ghossein is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ronald Ghossein have?
ScholarIQindexed works
Ronald Ghossein has 887 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ronald Ghossein have?
ScholarIQcitation count
Ronald Ghossein has 74,272 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ronald Ghossein?
ScholarIQh-index
Ronald Ghossein has an h-index of 117 in OpenAlex.
What is the i10-index of Ronald Ghossein?
ScholarIQi10-index
Ronald Ghossein has an i10-index of 310 in OpenAlex.
What is the ORCID of Ronald Ghossein?
ScholarIQorcid
The ORCID for Ronald Ghossein is on the source record.
What is the OpenAlex record for Ronald Ghossein?
ScholarIQopenalex
The OpenAlex for Ronald Ghossein is on the source record.
What are the most-cited papers on Ronald Ghossein?
ScholarIQmost cited works
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
Yuri E. Nikiforov, Raja R. Seethala, Giovanni Tallini, Zubair Baloch, Fulvio Basolo, Lester D.�R. Thompson, Justine A. Barletta, Bruce M. Wenig, Abir Al Ghuzlan, Kennichi Kakudo, Thomas J. Giordano, Venâncio Avancini Ferreira Alves, Elham Khanafshar, L. Sylvia, Adel K. El‐Naggar, William E. Gooding, Steven P. Hodak, Ricardo V. Lloyd, Guy Maytal, Özgür Mete, Marina N. Nikiforova, Vânia Nosé, Mauro Papotti, David Poller, Peter M. Sadow, Arthur S. Tischler, R. Michael Tuttle, Kathryn B. Wall, Virginia A. LiVolsi, Gregory W. Randolph, Ronald Ghossein
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for <i>BRAF, PIK3CA</i> , and <i>AKT1</i>
Julio C. Ricarte‐Filho, Mabel Ryder, Dhananjay Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David B. Solit, Jeffrey A. Knauf, R. Michael Tuttle, Ronald Ghossein, James A. Fagin
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
Debyani Chakravarty, Elmer Santos, Mabel Ryder, Jeffrey A. Knauf, Xiao-Hui Liao, Brian L. West, Gideon Bollag, Richard Kolesnick, Tin Htwe Thin, Neal Rosen, Pat Zanzonico, Steven M. Larson, Samuel Refetoff, Ronald Ghossein, James A. Fagin
Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i> -Mutant Thyroid Carcinomas
Cristina Montero‐Conde, Sergio Ruiz‐Llorente, José Miguel Domínguez, Jeffrey A. Knauf, Agnès Viale, Eric J. Sherman, Mabel Ryder, Ronald Ghossein, Neal Rosen, James A. Fagin
Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative Review
Andrés Coca‐Pelaz, Jatin P. Shah, Juan C. Hernandez‐Prera, Ronald Ghossein, Juan P. Rodrigo, Dana M. Hartl, Kerry D. Olsen, Ashok R. Shaha, Mark Zafereo, Carlos Suárez, Iain J. Nixon, Gregory W. Randolph, Antti Mäkitie, Luiz Paulo Kowalski, Vincent Vander Poorten, Álvaro Sanabria, Orlando Guntinas‐Lichius, Ricard Simó, Peter Zbären, Peter Angelos, Avi Khafif, Alessandra Rinaldo, Alfio Ferlito